• Explore /
  • Poster
  • / Predictive multi-omics analysis of BPM31510 in combination with gemcitabine in a phase 2 study of advanced pancreatic ductal adenocarcinoma (PDAC).

Predictive multi-omics analysis of BPM31510 in combination with gemcitabine in a phase 2 study of advanced pancreatic ductal adenocarcinoma (PDAC).

Abstract Poster

Authors

Madappa Kundranda

Madappa N. Kundranda

Banner MD Anderson Cancer Center, Gilbert, AZ

Madappa N. Kundranda , Can Bruce , Elder Granger , Brian Berman , Vijay Modur , Rangaprasad Sarangarajan , Anna A. Niewiarowska , Lynne A. Bui , James Fredric Strauss , Angela Tatiana Alistar , Sant P. Chawla , Roopinder Gillmore , Manuel Hidalgo , Arianne Lyng , Poornima Tekumalla , Greg M. Miller , Michael Kiebish , Niven R. Narain , David Propper

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT02650804

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 696)

DOI

10.1200/JCO.2024.42.3_suppl.696

Abstract #

696

Poster Bd #

N5

Abstract Disclosures

Similar Posters

First Author: Manish A. Shah

First Author: Juan José Soto

First Author: Junli Xue

First Author: Colin D. Weekes